[62] The mystery of gross haematuria in a patient on leflunomide: A case report and literature review
Objective: To report a case of gross haematuria in a patient on leflunomide. In 1998, the USA Food and Drug Administration approved leflunomide for the treatment of active rheumatoid arthritis. Leflunomide is classified as a disease-modifying anti-rheumatic drug (DMARD), which has immunomodulatory,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ac67fb1fcf304d33a374d1cb6e0ee89f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|